Paraquat Parkinson's Lawsuit
A September 11 order canceled the September 15 hearing concerning attorney Mark DiCello’s cases.
Official sourceA dated record of changes made from official court, agency, JPML and settlement-administration sources.
A September 11 order canceled the September 15 hearing concerning attorney Mark DiCello’s cases.
Official sourceThe fairness hearing was held September 14; the administrator says the court will now decide whether to approve the settlement, with timing unknown.
Official sourceJPML reports 15,264 pending actions on September 1, 2026, compared with 15,246 on August 3; 19,840 total historical actions are reported separately.
Official sourceCMO 26O moves Group B case-selection and expert-discovery proposals to November 20, 2026.
Official sourceCMO 33F sets thyroid/liver-cancer expert-motion responses for November 20, 2026 and replies for January 22, 2027; it does not set a trial.
Official sourceThe administrator confirms four water-system settlements have final approval; the Phase Two water-system claims deadline was July 31, 2026.
Official sourceThe Navy continues reviewing existing claims and requesting supporting records; new administrative claims remain closed.
Official sourceThe Navy portal supports claim-status checks, document uploads and claim-specific messages for existing claims.
Official sourceDOJ distinguishes accepted EO payment processing from the uncertain timing of an initial offer.
Official sourceJPML reports 6,403 pending actions on September 1, 2026, compared with 6,294 on August 3; 6,510 total historical actions are reported separately.
Official sourceCMO 12 confirms a private settlement and cancellation of the original December Pilot trial; the September 18 Rule 702 hearing remains listed for ongoing litigation.
Official sourceThe August 5 CMO 13 appoints BrownGreer PLC as settlement administrator to review records and determine eligibility.
Official sourceThe August 10 CMO 14 identifies November 30, 2026 as the settlement registration deadline and sets procedures for continuing claims.
Official sourceJPML reports 4,022 pending actions on September 1, 2026, compared with 3,928 on August 3; 4,056 total historical actions are reported separately.
Official sourceAn August 28 order rescheduled the Rule 702 evidentiary hearing to September 14–18, 2026. It is not a jury trial.
Official sourceThe separate NAION vision-loss MDL-3163 has 216 pending actions as of September 1, compared with 200 on August 3.
Official sourceThe public MDL orders checked September 14 contain no announced bellwether trial date or settlement program.
Official sourceJPML reports 6,666 pending actions on September 1, 2026, compared with 6,665 on August 3; 8,488 total historical actions are reported separately.
Official sourceCMO 24 identifies the September 3, 2025 agreement and the special master’s role in eligibility, offers and opt-out information.
Official sourceJune 2 and June 3 orders select specified opt-out cases for limited discovery; they do not create a public payout formula.
Official sourceJPML reports 3,925 pending actions on September 1, 2026, compared with 3,932 on August 3; 5,323 total historical actions are reported separately.
Official sourceThe administrator lists June 4, 2026 as the objection and exclusion deadline; later benefit deadlines depend on final approval and appeals.
Official sourceThe Supreme Court decided Monsanto v. Durnell on June 25, 2026, holding the label-based failure-to-warn claim at issue expressly preempted by FIFRA.
Official sourceJPML reports 3,208 pending actions on September 1, 2026, compared with 3,137 on August 3; 3,383 total historical actions are reported separately.
Official sourceThe court-linked calendar lists February 8, 2027 for the school-district bellwether jury trial, with jury selection February 3.
Official sourceThe same calendar lists the state attorneys general trial against Meta from August 17, 2026; that schedule is separate from an individual injury trial.
Official sourceThe federal court’s September 8 recent filings list conditional transfer order CTO-87, confirming continuing MDL transfers.
Official sourceJPML reports 1,827 pending actions on September 1, 2026, compared with 1,827 on August 3; 1,908 total historical actions are reported separately.
Official sourceCMO 23, entered July 16, governs provider depositions in the core discovery pool.
Official sourceThe bellwether protocol schedules core-pool depositions through January 15, 2027 and selection of 15 trial-pool cases on January 29, 2027.
Official sourceMarch 2028 appears in the protocol as a proposed first trial setting, not an entered trial date.
Official sourceJPML reports 23,316 pending actions and 25,213 historical actions in MDL-2846.
Official sourcePending actions decreased by 5 from 23,321 on August 3, 2026. This is a net docket change, not a count of new claims.
Official sourceJPML reports 3,734 pending actions and 3,980 historical actions in MDL-3081.
Official sourceThe pending count is unchanged from 3,734 on August 3, 2026.
Official sourceJPML reports 12,129 pending actions and 16,561 historical actions in MDL-3060.
Official sourcePending actions increased by 350 from 11,779 on August 3, 2026. This is a net docket change, not a count of new claims.
Official sourceJPML reports 69,250 pending actions and 71,935 historical actions in MDL-2738.
Official sourcePending actions increased by 336 from 68,914 on August 3, 2026. This is a net docket change, not a count of new claims.
Official sourceJPML reports 4,185 pending actions and 4,503 historical actions in MDL-2974.
Official sourcePending actions increased by 29 from 4,156 on August 3, 2026. This is a net docket change, not a count of new claims.
Official sourceCMO 24 sets a second-wave defendant discovery schedule, including September 29 responses and July 15, 2027 oral fact discovery.
Official sourceDOJ reports more than $1 billion in settlement offers and more than $827 million paid across CLJA settlements.
Official sourceJ&J disclosed a conditional $5.5 billion ovarian-talc proposal requiring at least 95% participation.
Official sourceThe disclosed company funding begins with no more than $3 billion in 2027; it is not a claimant payment date.
Official sourceCMO 46 addressed Cook trial preparation, Miller pool selection and Divelbliss expert briefing. Subsequent outcomes are not verified here.
Official sourceThe Rickard jury verdict was filed in favor of the defense. It does not decide other plaintiffs’ claims.
Official sourceA special master filed recommendations on Rule 702 expert-admissibility motions, distinct from any jury verdict.
Official sourceThe settlement special master appointment does not itself signal an imminent settlement, CMO 17 explains.
Official sourceCMO 56 established a qualified settlement fund for eligible settling claimants.
Official sourceCMO 55 schedules unresolved-claim settlement sessions to begin on or about January 4, 2027.
Official source